Marinus Pharmaceuticals, Inc. (MRNS)
USD 0.24
(-1.38%)
USD 0.24
(-1.38%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -118 Million | -112.88 Million | -55.47 Million | -60.91 Million | -48.63 Million | -27.84 Million |
| Net Income | -141.4 Million | -19.81 Million | -98.77 Million | -67.47 Million | -54.12 Million | -36.72 Million |
| Depreciation & Amortization | 551 Thousand | 418 Thousand | 355 Thousand | 334 Thousand | 278 Thousand | 127 Thousand |
| Deferred income taxes | 444 Thousand | - | -687 Thousand | 3000.00 | 34 Thousand | - |
| Stock-based compensation | 15.56 Million | 14.89 Million | 13.86 Million | 7.64 Million | 5.67 Million | 4.78 Million |
| Change in working capital | 2.16 Million | -6.09 Million | 28.69 Million | -2.04 Million | -590 Thousand | 4.04 Million |
| Other non-cash items | 4.67 Million | -102.28 Million | 1.06 Million | 626 Thousand | 94 Thousand | -79 Thousand |
| Investing Cash Flow | -28.6 Million | 105.77 Million | -1.41 Million | -738 Thousand | 3.88 Million | 19.91 Million |
| Investments in PPE | -119 Thousand | -1.77 Million | -2.88 Million | - | -388 Thousand | -83 Thousand |
| Acquisitions | 9000.00 | 171 Thousand | - | - | -4.26 Million | - |
| Investment purchases | -51.99 Million | -171 Thousand | - | -8.93 Million | -2.72 Million | -24.89 Million |
| Sales/Maturities of investments | 23.5 Million | 107.37 Million | 1.47 Million | 8.19 Million | 6.99 Million | 20 Million |
| Other Investing Activities | -28.48 Million | 171 Thousand | 1.47 Million | -738 Thousand | 4.26 Million | 24.89 Million |
| Financing Cash Flow | 26.62 Million | 124.73 Million | 41.31 Million | 109.21 Million | 67.96 Million | 42.12 Million |
| Debt repayment | - | -42 Thousand | -40.11 Million | - | - | -193 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 26.62 Million | 64.47 Million | 1.19 Million | 108.19 Million | 67.96 Million | 42.31 Million |
| Other Financing Activities | 4.8 Million | 60.3 Million | 80.22 Million | 1.02 Million | 67.96 Million | 42.31 Million |
| Accounts receivables | 2.61 Million | -5.57 Million | -853 Thousand | - | - | - |
| Accounts payables | 2.1 Million | 3.75 Million | 7.84 Million | 1.87 Million | 890 Thousand | -2.12 Million |
| Inventory | - | - | 853 Thousand | - | - | - |
| Other working capital | -2.55 Million | -4.26 Million | 20.85 Million | -3.91 Million | -1.48 Million | 6.16 Million |
| Cash at beginning of period | 240.55 Million | 122.92 Million | 138.5 Million | 90.94 Million | 67.72 Million | 33.53 Million |
| Cash at end of period | 120.57 Million | 240.55 Million | 122.92 Million | 138.5 Million | 90.94 Million | 67.72 Million |
| Capital Expenditure | -119 Thousand | -1.77 Million | -2.88 Million | - | -388 Thousand | -83 Thousand |
| Effect of forex changes on cash | 21.82 Million | - | - | - | - | - |
| Net cash flow / Change in cash | -119.97 Million | 117.62 Million | -15.58 Million | 47.56 Million | 23.21 Million | 34.19 Million |
| Free Cash Flow | -118.12 Million | -114.66 Million | -58.36 Million | -60.91 Million | -49.02 Million | -27.92 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -35.82 Million | -38.66 Million | -141.4 Million | -41.76 Million | -32.97 Million | -31.93 Million |
| Depreciation & Amortization | 140 Thousand | 131 Thousand | 551 Thousand | 125 Thousand | 142 Thousand | 127 Thousand |
| Deferred income taxes | - | - | 444 Thousand | 1.49 Million | -327 Thousand | -441 Thousand |
| Stock-based compensation | 4.91 Million | 5.19 Million | 15.56 Million | 3.92 Million | 4 Million | 3.89 Million |
| Change in working capital | -2.66 Million | -5.57 Million | 2.16 Million | 9.93 Million | 2.19 Million | 2.17 Million |
| Other non-cash items | 11.63 Million | 9.17 Million | 4.67 Million | -704 Thousand | 1.78 Million | 1.82 Million |
| Investing Cash Flow | 8.96 Million | 20.88 Million | -28.6 Million | 6.46 Million | 11.92 Million | 5 Million |
| Investments in PPE | -38 Thousand | - | -119 Thousand | -34 Thousand | -85 Thousand | - |
| Acquisitions | - | - | 9000.00 | -9000.00 | 5000.00 | 4000.00 |
| Investment purchases | - | - | -51.99 Million | 5000.00 | -5000.00 | - |
| Sales/Maturities of investments | 9 Million | 20.88 Million | 23.5 Million | 6.5 Million | 12 Million | 5 Million |
| Other Investing Activities | 9 Million | 20.88 Million | -28.48 Million | 6.5 Million | 5000.00 | 5 Million |
| Financing Cash Flow | -17.69 Million | 257 Thousand | 26.62 Million | 661 Thousand | 25.9 Million | 237 Thousand |
| Debt repayment | -17.69 Million | - | - | -737 Thousand | -316 Thousand | -247 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -76 Thousand | - | - |
| Common Stock Issuance | - | 257 Thousand | 26.62 Million | 25.84 Million | 299 Thousand | 484 Thousand |
| Other Financing Activities | -17.69 Million | 257 Thousand | 4.8 Million | -24.44 Million | 25.92 Million | 237 Thousand |
| Accounts receivables | 518 Thousand | 522 Thousand | 2.61 Million | 534 Thousand | 510 Thousand | 1.02 Million |
| Accounts payables | -3.85 Million | -2.26 Million | 2.1 Million | 5.66 Million | 529 Thousand | -371 Thousand |
| Inventory | - | - | - | 1.69 Million | -1.03 Million | -653.99 Thousand |
| Other working capital | 1.19 Million | -3.31 Million | -2.55 Million | 4.27 Million | 2.19 Million | 2.17 Million |
| Cash at beginning of period | 104.25 Million | 120.57 Million | 240.55 Million | 140.43 Million | 127.78 Million | 146.9 Million |
| Cash at end of period | 64.67 Million | 104.25 Million | 120.57 Million | 120.57 Million | 140.43 Million | 127.78 Million |
| Capital Expenditure | -38 Thousand | - | -119 Thousand | -34 Thousand | -85 Thousand | - |
| Effect of forex changes on cash | - | - | 21.82 Million | - | - | - |
| Net cash flow / Change in cash | -39.57 Million | -16.31 Million | -119.97 Million | -19.86 Million | 12.65 Million | -19.11 Million |
| Free Cash Flow | -30.87 Million | -37.46 Million | -118.12 Million | -27.02 Million | -25.25 Million | -24.35 Million |
NWFL
DFMTF
PDMI
FGPR
SMTOY
PAP